Extractive colorimetric method development and validation for erlotinib in bulk and tablet dosage form
G. Usha Rani, B. Chandrasekhar, N. Devanna
Pages: 176-179
Designing, molecular docking, and dynamics simulations studies of 1,2,3-triazole clamped Uracil-Coumarin hybrids against EGFR tyrosine kinase
Mohit Sanduja, Jyoti Gupta, Ravi Rawat, Uttam Singh, Saurabh M. Verma
DOI: 10.7324/JAPS.2020.103001Pages: 001-011
Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib vs. gefitinib vs. afatinib) in non-small-cell lung cancer
Fitri Nurhayati, Yusi Anggriani, Elisna Syahruddin, Hesty Utami Ramadaniati, Tri Kusumaeni
DOI: 10.7324/JAPS.2021.110411Pages: 088-095
System biology and chemoinformatics approaches to decode the molecular mechanisms of Chrysin against colon cancer
Namit Kudatarkar, Sunil Jalalpure, Vishal S. Patil, Bhaskar Kurangi
DOI: 10.7324/JAPS.2021.110907Pages: 057-065
